New method could detect tiny fragments of cancerous genetic material in the blood of lung cancer patients precisely by determining the sequence of molecules in DNA, according to a research published in the cancer journal iAnnals of Oncology /i.
Results from analyses of so-called "liquid biopsies" in patients with non-small cell lung cancer (NSCLC) show that it is possible to identify the genetic variants that are either driving the cancer or making it resistant to treatment.
This offers ...
New method could detect tiny fragments of cancerous genetic material in the blood of lung cancer patients precisely by determining the sequence of molecules in DNA, according to a research published in the cancer journal iAnnals of Oncology /i.
Results from analyses of so-called "liquid biopsies" in patients with non-small cell lung cancer (NSCLC) show that it is possible to identify the genetic variants that are either driving the cancer or making it resistant to treatment.
This offers ...